362 related articles for article (PubMed ID: 23463353)
1. Prediction of drug disposition on the basis of its chemical structure.
Stepensky D
Clin Pharmacokinet; 2013 Jun; 52(6):415-31. PubMed ID: 23463353
[TBL] [Abstract][Full Text] [Related]
2. Computational modeling of human oral bioavailability: what will be next?
Cabrera-Pérez MÁ; Pham-The H
Expert Opin Drug Discov; 2018 Jun; 13(6):509-521. PubMed ID: 29663836
[TBL] [Abstract][Full Text] [Related]
3. The Promises of Quantitative Proteomics in Precision Medicine.
Prasad B; Vrana M; Mehrotra A; Johnson K; Bhatt DK
J Pharm Sci; 2017 Mar; 106(3):738-744. PubMed ID: 27939376
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
Poulin P; Theil FP
J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
[TBL] [Abstract][Full Text] [Related]
5. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
Johnson TN; Rostami-Hodjegan A
Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
[TBL] [Abstract][Full Text] [Related]
6. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
Lüpfert C; Reichel A
Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
[TBL] [Abstract][Full Text] [Related]
7. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development.
del Amo EM; Vellonen KS; Kidron H; Urtti A
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):215-26. PubMed ID: 25603198
[TBL] [Abstract][Full Text] [Related]
9. Application of a physiologically based pharmacokinetic model informed by a top-down approach for the prediction of pharmacokinetics in chronic kidney disease patients.
Sayama H; Takubo H; Komura H; Kogayu M; Iwaki M
AAPS J; 2014 Sep; 16(5):1018-28. PubMed ID: 24912798
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
[TBL] [Abstract][Full Text] [Related]
11. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
Poulin P; Burczynski FJ; Haddad S
J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
[TBL] [Abstract][Full Text] [Related]
12. The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives.
Pan Y; Hsu V; Grimstein M; Zhang L; Arya V; Sinha V; Grillo JA; Zhao P
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S122-31. PubMed ID: 27385170
[TBL] [Abstract][Full Text] [Related]
13. A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.
Poulin P
J Pharm Sci; 2015 Jul; 104(7):2359-68. PubMed ID: 25943586
[TBL] [Abstract][Full Text] [Related]
14. Improving ADMET Prediction Accuracy for Candidate Drugs: Factors to Consider in QSPR Modeling Approaches.
Chen M; Yang J; Tang C; Lu X; Wei Z; Liu Y; Yu P; Li H
Curr Top Med Chem; 2024; 24(3):222-242. PubMed ID: 38083894
[TBL] [Abstract][Full Text] [Related]
15. BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.
Graf JF; Scholz BJ; Zavodszky MI
J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):37-54. PubMed ID: 22161221
[TBL] [Abstract][Full Text] [Related]
16. Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System.
Benet LZ
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):162-7. PubMed ID: 20002064
[TBL] [Abstract][Full Text] [Related]
17. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
[TBL] [Abstract][Full Text] [Related]
18. Dose selection based on physiologically based pharmacokinetic (PBPK) approaches.
Jones HM; Mayawala K; Poulin P
AAPS J; 2013 Apr; 15(2):377-87. PubMed ID: 23269526
[TBL] [Abstract][Full Text] [Related]
19. Successful Prediction of Human Pharmacokinetics by Improving Calculation Processes of Physiologically Based Pharmacokinetic Approach.
Mayumi K; Ohnishi S; Hasegawa H
J Pharm Sci; 2019 Aug; 108(8):2718-2727. PubMed ID: 30876861
[TBL] [Abstract][Full Text] [Related]
20. Chirality and pharmacokinetics: an area of neglected dimensionality?
Hutt AJ
Drug Metabol Drug Interact; 2007; 22(2-3):79-112. PubMed ID: 17708062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]